Targeting tumor-related immunosuppression for cancer immunotherapy.
Endocr Metab Immune Disord Drug Targets. 2006 Sep;6(3):233-7. doi: 10.2174/187153006778250019.
Endocr Metab Immune Disord Drug Targets. 2006.
PMID: 17017974
Review.